Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (261-270 of 328) with videos related to

Pageof 33
Sort By:
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
JAMA Network Open|June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative DurvalumabYufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Oncotarget|August 7, 2019
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Lakshmi Veeranki, Zhimin Tong, Rashmi Dokey, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Nuclear Medicine Communications|October 13, 2017
Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancerLucas Goense, Sophie E Heethuis, Peter S N van Rossum, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trialYufei Liu, Luyang Yao, Neda Kalhor, et al.
Disease Models & Mechanisms|November 17, 2019
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveriesOmkara Lakshmi Veeranki, Zhimin Tong, Alicia Mejia, et al.
Pageof 33

Showing results (261-270 of 328) with videos related to

Sort By:
Pageof 33
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
JAMA Network Open|June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative DurvalumabYufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Oncotarget|August 7, 2019
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Lakshmi Veeranki, Zhimin Tong, Rashmi Dokey, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Nuclear Medicine Communications|October 13, 2017
Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancerLucas Goense, Sophie E Heethuis, Peter S N van Rossum, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trialYufei Liu, Luyang Yao, Neda Kalhor, et al.
Disease Models & Mechanisms|November 17, 2019
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveriesOmkara Lakshmi Veeranki, Zhimin Tong, Alicia Mejia, et al.
Pageof 33